Lactobacillus Acidophilus and Bifidobacterium Animalis Subsp. Lactis, Maintenance Treatment in Ulcerative Colitis

Hvidovre University Hospital

Status and phase: Terminated; Phase 2

Conditions: Ulcerative Colitis

Treatments: Drug: lactobacilus acidophilus & bifidobacterium animalis/lactis

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT00268164

AB coul

Details and patient eligibility

About

The purpose of this study is to determine whether the lactic acid bacteria " Lactobacillus acidophilus (LA5) and Bifidobacterium animalis subsp. lactis (BB12)" is effective as maintenance treatment in ulcerative colitis.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with ulerative colitis ording to well-known diagnostic criteria and remission for at least one month, and with at least one relapse within the last year.

Exclusion criteria

• Pregnancy and lactating
• Serious underlying disease other than UC
• Former gastrointestinal resections
• Medication for UC other than mesalazine
• Known allergic reactions towards compounds in the study drug.
• Expected lack of compliance due to mental state or language problems

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind